Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for acute Charcot foot in diabetes
NL-OMON50445Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Charcot neuroarthropathy (CN) comparing Denosumab with Placebo (2 arms). Primary endpoints: Time to cessation of total contact cast boot and Curation of foot fractures. Started Sep 2017; status: completed.
02
Drugs
denosumab
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on NL-OMON50445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50445.